Amanote Research

Amanote Research

    RegisterSign In

New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2020.2503
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
Date

February 1, 2020

Authors
Thomas DanneLutz HeinemannJan Bolinder
Publisher

Mary Ann Liebert Inc


Related search

New Approaches to Insulin Therapy.

Annals of Internal Medicine
Internal MedicineMedicine
1982English

The Conformation of Insulin-Like Growth Factors: Relationships With Insulins

Journal of Cell Science
Cell Biology
1985English

Insulin Therapy and Hypoglycemia

Endocrinology and Metabolism Clinics of North America
EndocrinologyMetabolismDiabetes
2012English

How Can Biosimilars Change the Trajectory of Breast Cancer Therapy?

Expert Review of Anticancer Therapy
OncologyPharmacology
2020English

Insulin Therapy and Hypoglycemia

2002English

Clinical Benefits of Switching Type 2 Diabetes Patients From Human Insulins to Insulin Analogs

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2013English

The Future of Biological Therapy: A Pathway Forward for Biosimilars

GaBI Journal
Drug GuidesPharmacy
2013English

Diabetes I: Insulins.

BMJ
1983English

Biosimilars

ESMO Open
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy